From Wikipedia, the free encyclopedia
Jump to: navigation, search

Mondobiotech is a Swiss-based biotechnology company focused on developing human peptides as medicaments for patients affected by rare diseases.


Mondobiotech was founded in 2000 by Fabio Cavalli and Dorian Bevec.[1] In March 2012, Pharma Times reported that mondoBIOTECH was “financially troubled” and was in exclusive negotiations with Pierrel Research, the contact research division of the Italian company Pierrel.[2]

Research and development[edit]

Mondobiotech creates drugs for rare diseases.


  • Winner of the Swiss Life Sciences Prize 2005.
  • Selected Technology Pioneer 2008 by The World Economic Forum.

Notes and references[edit]

  1. ^
  2. ^ Mansell, Peter (6 March 2012). "Pierrel in negotiations for mondoBIOTECH merger". Pharma Times. Retrieved 9 March 2015. 

See also[edit]

External links[edit]